Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation.

about

Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation.

Item

http://www.wikidata.org/entity/Q55007009

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Genetic polymorphism of SLC31A ...... microRNA-mediated regulation.

@en

Genetic polymorphism of SLC31A ...... microRNA-mediated regulation.

@nl

type

Item

label

Genetic polymorphism of SLC31A ...... microRNA-mediated regulation.

@en

Genetic polymorphism of SLC31A ...... microRNA-mediated regulation.

@nl

prefLabel

Genetic polymorphism of SLC31A ...... microRNA-mediated regulation.

@en

Genetic polymorphism of SLC31A ...... microRNA-mediated regulation.

@nl

P1476

Genetic polymorphism of SLC31A ...... microRNA-mediated regulation.

@en

P2093

Baohui Han

http://www.w3.org/2001/XMLSchema#string

Chang Sun

http://www.w3.org/2001/XMLSchema#string

Chunxue Bai

http://www.w3.org/2001/XMLSchema#string

Daru Lu

http://www.w3.org/2001/XMLSchema#string

Haijian Wang

http://www.w3.org/2001/XMLSchema#string

Ji Qian

http://www.w3.org/2001/XMLSchema#string

Jibin Xu

http://www.w3.org/2001/XMLSchema#string

Jingbo Qie

http://www.w3.org/2001/XMLSchema#string

Jiucun Wang

http://www.w3.org/2001/XMLSchema#string

Junjie Wu

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

The copper transporter CTR1 provides an essential function in mammalian embryonic development

A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia.

Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor.

Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.

Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy.

P304

23860-23877

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24794

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29844858

http://www.w3.org/2001/XMLSchema#string

P932

5963629

http://www.w3.org/2001/XMLSchema#string